VantAI
Zeenat Patrawala is an accomplished professional with extensive experience in leadership roles across various organizations. Currently serving as Chief Business Officer at VantAI and holding advisory positions at Parker & Ace, CTIC Capital, Belay, TMA Precision Health, and People Science, Zeenat is instrumental in driving business strategy and growth. As a Founding Member of The Fem League and a Fractional CBO at Blair Street Strategy, Zeenat demonstrates a commitment to both innovation and empowerment in healthcare. Previous roles include VP of Business Development at Onc.AI and Non-Executive Director at Intelligent Medicine Acquisition Corp. Zeenat's educational background includes degrees from prestigious institutions such as Massachusetts Institute of Technology, Harvard University, Melbourne Business School, and Cornell University, specializing in biomedical enterprise and finance.
This person is not in any teams
This person is not in any offices
VantAI
1 followers
VantAI pairs bleeding-edge machine learning techniques with deep systems biology expertise to build computational models that uncover hidden relationships between molecules, targets, and diseases. These models power a best-in-class solution that identifies and generates new molecular entities for targets of interest, repurposes existing molecules at any stage of development, uncovers accurate ADME and toxicological insights, and predicts adverse events likely to influence trial success from deep analysis of systems-based pharmacogenomics. VantAI's in silico platform specializes in modelling complex protein-protein interactions, powering the discovery of biologics and protein degraders in addition to small-molecule drugs. It has helped leading biopharma partners launch new development programs--or revitalize old ones--at a fraction of the time and cost of traditional methods.